In vivo cell tracking via 18F-fluorodeoxyglucose labeling: A review of the preclinical and clinical applications in cell-based diagnosis and therapy

Clinical Imaging

Volumn 37, Issue 1, 2013, Pages 28-36

  Wu, Chenxi ^a   Ma, Guotao ^a   Li, Jing ^b   Zheng, Kun ^a   Dang, Yonghong ^a   Shi, Ximin ^a   Sun, Yi ^a   Li, Fang ^a   Zhu, Zhaohui ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

18F FDG labeling; Cell tracking; Cell based treatment; Clinical application; Inflammation imaging; PET CT

Indexed keywords

CANCER IMMUNOTHERAPY; CELL TRACKING; CELL-BASED; CLINICAL APPLICATION; F-FLUORODEOXYGLUCOSE; FUNCTIONAL CELLS; HUMAN PATIENTS; IN-VIVO; PET TRACER; REPORTER GENE; TRACKING CELLS;

POSITRON EMISSION TOMOGRAPHY; STEM CELLS; TRACKING (POSITION);

CYTOLOGY;

FLUORODEOXYGLUCOSE F 18; HEXADECYL 4 FLUORODEOXYGLUCOSE F 18; N SUCCIMIDYL 4 FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG;

ACCURACY; BIOACCUMULATION; CANCER IMMUNOTHERAPY; CARDIAC STEM CELL; CELL LABELING; CELL THERAPY; CELL TRACKING; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTODIAGNOSIS; HALF LIFE TIME; HEART INFARCTION; HUMAN; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE ACTIVATION; MOLECULAR IMAGING; NONHUMAN; PANCREAS ISLET CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; CELL TRACKING; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STAINING AND LABELING; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84872399695     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2012.02.023     Document Type: Review

References (50)

1. Kiessling F Noninvasive cell tracking. Handb Exp Pharmacol 2008, 185(Pt. 2):305-321.
2. Thompson M, Wall DM, Hicks RJ, Prince HM In vivo tracking for cell therapies. Q J Nucl Med Mol Imaging 2005, 49(4):339-348.
3. Daley GQ, Scadden DT Prospects for stem cell-based therapy. Cell 2008, 132(4):544-548.
4. Bengel FM, Schachinger V, Dimmeler S Cell-based therapies and imaging in cardiology. Eur J Nucl Med Mol Imaging 2005, 32(Suppl 2):S404-S416.
5. Hong H, Yang Y, Zhang Y, Cai W Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem 2010, 10(12):1237-1248.
6. Tumeh PC, Radu CG, Ribas A PET imaging of cancer immunotherapy. J Nucl Med 2008, 49(6):865-868.
7. Love C, Palestro CJ Radionuclide imaging of infection. J Nucl Med Technol 2004, 32(2):47-57.
8. Hughes DK Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-Oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate. J Nucl Med Technol 2003, 31(4):196-201.
9. Osman S, Danpure HJ The use of 2-[18F] fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992, 19(2):183-190.
10. Forstrom LA, Mullan BP, Hung JC, Lowe VJ, Thorson LM 18F-FDG labeling of human leukocytes. Nucl Med Commun 2000, 21(7):685-690.
11. Pellegrino D, Bonab AA, Dragotakes SC, Pitman JT, Mariani G, Carter EA, et al. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med 2005, 46(9):1522-1530.
12. Rini JN, Bhargava KK, Tronco GG, Singer C, Caprioli R, Marwin SE, et al. PET with FDG-labeled leukocytes versus scintigraphy with 111In-Oxine-labeled leukocytes for detection of infection. Radiology 2006, 238(3):978-987.
13. Dumarey N, Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V, et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 2006, 47(4):625-632.
14. Ritchie D, Mileshkin L, Wall D, Bartholeyns J, Thompson M, Coverdale J, et al. In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma. Cancer Immunol Immunother 2007, 56(2):155-163.
15. Meier R, Piert M, Piontek G, Rudelius M, Oostendorp RA, Senekowitsch-Schmidtke R, et al. Tracking of 18F-FDG-labeled natural killer cells to HER2/neu-positive tumors. Nucl Med Biol 2008, 35(5):579-588.
16. Botti C, Negri DRM, Seregni E, Ramakrishna V, Arienti F, Maffioli L, et al. Comparison of three different methods for radiolabeling human activated T lymphocytes. Eur J Nucl Med 1997, 24(5):497-504.
17. Agger R, Petersen MS, Petersen CC, Hansen SB, Stodkilde-Jorgensen H, Skands U, et al. T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J Immunother 2007, 30(1):29-39.
18. Hauptman PJ, O'Connor KJ Procurement and allocation of solid organs for transplantation. N Engl J Med 1997, 336(6):422-431.
19. Stock PG, Bluestone JA Beta-cell replacement for type I diabetes. Annu Rev Med 2004, 55(1):133-156.
20. Moore A, Bonner-Weir S, Weissleder R Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes 2001, 50(10):2231-2236.
21. Paty BW, Bonner-weir S, Laughlin MR, McEwan AJ, Shapiro AM Toward development of imaging modalities for islets after transplantation: insights from the national institutes of health workshop on beta cell imaging. Transplantation 2004, 77(8):1133-1137.
22. Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Stout DB, et al. Noninvasive imaging of islet grafts using positron-emission tomography. Proc Natl Acad Sci USA 2006, 103(30):11294-11299.
23. Kim S, Doudet D, Studentov A, Nian C, Ruth TJ, Gambhir SS, et al. Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med 2006, 12(12):1423-1428.
24. Medarova Z, Moore A Non-invasive detection of transplanted pancreatic islets. Diabetes Obes Metab 2008, 10(Suppl. 4):88-97.
25. Eriksson O, Eichc T, Sundin A, Tibell A, Tufveson G, Andersson H, et al. Positron emission tomography in clinical islet transplantation. Am J Transplantation 2009, 9(12):2816-2824.
26. Eich T, Eriksson O, Lundgren T Visualization of early engraftment in clinical islet transplantation by positron emission tomography. N Engl J Med 2007, 356(26):2754-2755.
27. Toso C, Zaidi H, Morel P, Armanet M, Andres A, Pernin N, et al. Positron emission tomography imaging of early events after transplantation of islets of Langerhans. Transplantation 2005, 79(3):353-355.
28. Eich T, Eriksson O, Sundin A, Estrada S, Brandhorst D, Brandhorst H, et al. Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 2007, 84(7):893-898.
29. Shanthly N, Aruva MR, Zhang K, Mathew B, Thakur ML, et al. Stem cell: a regenerative pharmaceutical. Q J Nucl Med Mol Imaging 2006, 50(3):205-216.
30. Kaminek M, Meluzin J, Panovsky R, Janousek S, Mayer J, Prasek J, et al. Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by sestamibi SPECT/FDG PET imaging. J Nucl Cardiol 2008, 15(3):392-399.
31. Beeres SL, Bengel FM, Bartunek J, Atsma DE, Hill JM, Vanderheyden M, et al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol 2007, 49(11):1137-1148.
32. Chang GY, Xie X, Wu JC Overview of stem cells and imaging modalities for cardiovascular diseases. J Nucl Cardiol 2006, 13(4):554-569.
33. Frangioni JV, Hajjar RJ In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 2004, 110(21):3378-3384.
34. Tsui BM, Kraitchman DL Recent advances in small-animal cardiovascular imaging. J Nucl Med 2009, 50(5):667-670.
35. Musialek P, Tekieli L, Kostkiewicz M, Majka M, Szot W, Walter Z, et al. Randomized transcoronary delivery of CD34 (+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: early cardiac retention of 99mTc-labeled cells activity. J Nucl Cardiol 2011, 18(1):104-116.
36. Zhang Y, Ruel M, Beanlands RSB, deKemp RA, Suuronen EJ, DaSilva JN, et al. Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des 2008, 14(36):3835-3853.
37. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111(17):2198-2202.
38. Doyle B, Kemp BJ, Chareonthaitawee P, Reed C, Schmeckpeper J, Sorajja P, et al. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med 2007, 48(10):1708-1714.
39. Qian H, Yang Y, Huang J, Gao R, Dou K, Yang G, et al. Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts. J Cell Biochem 2007, 102(1):64-74.
40. Blocklet D, Toungouz M, Berkenboom G, Lambermont M, Unger P, Preumont N, et al. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006, 24(2):333-336.
41. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS, et al. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 2006, 47(8):1295-1301.
42. Weissleder R, Pittet MJ Imaging in the era of molecular oncology. Nature 2008, 452(7187):580-589.
43. Elhami E, Goertzen AL, Xiang B, Deng J, Stillwell C, Mzengeza S, et al. Viability and proliferation potential of adipose-derived stem cells following labeling with a positron-emitting radiotracer. Eur J Nucl Med Mol Imaging 2011, 38(7):1323-1334.
44. Paik JY, Lee KH, Byun SS, Choe YS, Kim BT Use of insulin to improve 18F-fluorodeoxyglucose labeling and retention for in vivo positron emission tomography imaging of monocyte trafficking. Nucl Med Commun 2002, 23(6):551-557.
45. Zhang Y, Thorn S, DaSilva JN, Lamoureux M, DeKemp RA, Beanlands RS, et al. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography. Circ Cardiovasc Imaging 2008, 1(3):197-204.
46. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods 2002, 260(1-2):137-148.
47. Ma B, Hankenson KD, Dennis JE, Caplan AI, Goldstein SA, Kilbourn MR A simple method for stem cell labeling with fluorine 18. Nucl Med Biol 2005, 32(7):701-705.
48. Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis (N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 2002, 99(5):3030-3035.
49. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117(3):379-387.
50. Bhargava KK, Gupta RK, Nichols KJ, Palestro CJ In-vitro human leukocyte labeling with 64Cu: an intraindividual comparison with 111In-oxine and 18F-FDG. Nucl Med Biol 2009, 36(5):545-549.